AU690474B2
(en)
*
|
1995-09-11 |
1998-04-23 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody againts alpha-chain of human interleukin 5 receptor
|
US6986890B1
(en)
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
JP3679406B2
(ja)
*
|
1998-05-20 |
2005-08-03 |
協和醗酵工業株式会社 |
遺伝子組換え抗体
|
EP1086956B1
(de)
*
|
1998-05-20 |
2009-04-15 |
Kyowa Hakko Kogyo Co., Ltd. |
Gen rekombinante antikörper
|
FR2783326B1
(fr)
*
|
1998-09-10 |
2000-12-01 |
Immunotech Sa |
Procede de detection ou de quantification des basophiles et des eosinophiles
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
ES2420835T3
(es)
*
|
1999-04-09 |
2013-08-27 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento para controlar la actividad de las moléculas inmunofuncionales
|
IT1306704B1
(it)
|
1999-05-26 |
2001-10-02 |
Sirs Societa Italiana Per La R |
Anticorpi monoclonali e suoi derivati sintetici o biotecnologici ingrado di agire come molecole antagoniste per il ngf.
|
ATE388167T1
(de)
*
|
1999-09-30 |
2008-03-15 |
Kyowa Hakko Kogyo Kk |
Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3
|
JP4668498B2
(ja)
*
|
1999-10-19 |
2011-04-13 |
協和発酵キリン株式会社 |
ポリペプチドの製造方法
|
US7404953B2
(en)
*
|
2000-02-15 |
2008-07-29 |
Kyowa Hakko Kogyo Co., Ltd. |
Methods using eosinophil-specific apoptosis inducer
|
WO2001064711A1
(fr)
*
|
2000-03-02 |
2001-09-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de separation et de purification de proteine
|
US20030023043A1
(en)
*
|
2000-03-02 |
2003-01-30 |
Kazuhisa Uchida |
Method of separating and purifying protein
|
DK1270595T3
(da)
|
2000-03-03 |
2008-11-10 |
Kyowa Hakko Kogyo Kk |
Anti-CCR4-antistof og dets fragment
|
FR2807767B1
(fr)
*
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
US7384632B2
(en)
*
|
2000-06-22 |
2008-06-10 |
Genentech, Inc. |
Agonist anti-trk-C monoclonal antibodies
|
US7064191B2
(en)
*
|
2000-10-06 |
2006-06-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
CA2424977C
(en)
*
|
2000-10-06 |
2008-03-18 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
CA2953239A1
(en)
*
|
2000-10-06 |
2002-04-18 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody composition-producing cell
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
WO2003018635A1
(en)
|
2001-08-31 |
2003-03-06 |
Kyowa Hakko Kogyo Co., Ltd. |
Human cdr-grafted antibodies and antibody fragments thereof
|
CA2481920A1
(en)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Antibody composition-containing medicament
|
JP2003310275A
(ja)
*
|
2002-04-30 |
2003-11-05 |
Kyowa Hakko Kogyo Co Ltd |
ヒトインスリン様成長因子に対する遺伝子組換え抗体
|
GB0210783D0
(en)
*
|
2002-05-10 |
2002-06-19 |
Polonelli Luciano |
Anti-microbial polypeptides
|
EP1388544A1
(de)
*
|
2002-07-31 |
2004-02-11 |
D. Collen Research Foundation vzw |
Anti-Idiotypische Antikörper gegen Factor VIII-Inhibitor und Verwendungen davon
|
ATE515514T1
(de)
|
2002-12-23 |
2011-07-15 |
Schering Corp |
Verwendungen von säuger-cytokin il-23 ; verwandte reagenzien
|
US8597911B2
(en)
|
2003-06-11 |
2013-12-03 |
Chugai Seiyaku Kabushiki Kaisha |
Process for producing antibodies
|
US7498415B2
(en)
|
2003-09-24 |
2009-03-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Recombinant antibody against human insulin-like growth factor
|
WO2005035583A1
(ja)
*
|
2003-10-08 |
2005-04-21 |
Kyowa Hakko Kogyo Co., Ltd. |
Il-5受容体に特異的に結合する抗体組成物
|
US20050226867A1
(en)
*
|
2003-10-08 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
IL-5R-specific antibody composition
|
EP1694850B1
(de)
*
|
2003-11-12 |
2011-06-29 |
Schering Corporation |
Plasmidsystem zur expression mehrerer gene
|
TW200530269A
(en)
|
2003-12-12 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Anti-Mpl antibodies
|
KR20060133049A
(ko)
*
|
2004-03-23 |
2006-12-22 |
일라이 릴리 앤드 캄파니 |
항-마이오스타틴 항체
|
CA2585977C
(en)
|
2004-10-28 |
2013-07-02 |
Kyowa Hakko Kogyo Co., Ltd. |
Remedy for endometriosis
|
US9493569B2
(en)
|
2005-03-31 |
2016-11-15 |
Chugai Seiyaku Kabushiki Kaisha |
Structural isomers of sc(Fv)2
|
EP3623473A1
(de)
|
2005-03-31 |
2020-03-18 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur herstellung von polypeptiden durch regulierung der anordnung
|
US9241994B2
(en)
|
2005-06-10 |
2016-01-26 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical compositions containing sc(Fv)2
|
EP1908482B1
(de)
|
2005-06-10 |
2017-09-06 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilisator für eine proteinzubereitung mit meglumin und seine verwendung
|
JP5095416B2
(ja)
|
2005-12-06 |
2012-12-12 |
協和発酵キリン株式会社 |
抗perp遺伝子組換え抗体
|
WO2007114325A1
(ja)
|
2006-03-31 |
2007-10-11 |
Chugai Seiyaku Kabushiki Kaisha |
二重特異性抗体を精製するための抗体改変方法
|
KR101463631B1
(ko)
*
|
2006-03-31 |
2014-11-19 |
추가이 세이야쿠 가부시키가이샤 |
항체의 혈중 동태를 제어하는 방법
|
US20080118978A1
(en)
|
2006-04-28 |
2008-05-22 |
Takashi Sato |
Anti-tumor agent
|
WO2007142277A1
(ja)
|
2006-06-06 |
2007-12-13 |
Kyowa Hakko Kirin Co., Ltd. |
ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
|
TWI419703B
(zh)
*
|
2006-06-08 |
2013-12-21 |
Chugai Pharmaceutical Co Ltd |
The use of anti-NR10 antibodies with neutralizing activity against human NR10 and Cynomolgus monkey NR10
|
US20110236374A1
(en)
|
2007-01-24 |
2011-09-29 |
Kyowa Hakko Kirin Co., Ltd. |
Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
|
JP5071942B2
(ja)
|
2007-01-24 |
2012-11-14 |
協和発酵キリン株式会社 |
エフェクター活性が増強された遺伝子組換え抗体組成物
|
KR100855299B1
(ko)
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
WO2008114733A1
(ja)
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
PT3072525T
(pt)
*
|
2007-05-14 |
2018-04-20 |
Astrazeneca Ab |
Métodos para reduzir os níveis de basófilos
|
RU2526512C2
(ru)
*
|
2007-09-26 |
2014-08-20 |
Чугаи Сейяку Кабусики Кайся |
Модифицированная константная область антитела
|
DK2202245T3
(en)
|
2007-09-26 |
2016-11-21 |
Chugai Pharmaceutical Co Ltd |
A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR
|
CN101939025B
(zh)
|
2007-12-05 |
2015-03-25 |
中外制药株式会社 |
搔痒症治疗药
|
EP3095862B9
(de)
|
2007-12-05 |
2021-04-14 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-nr10-antikörper und seine verwendung
|
AU2008332296A1
(en)
|
2007-12-05 |
2009-06-11 |
Kyowa Hakko Kirin Co., Ltd. |
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
|
WO2009095478A1
(en)
|
2008-01-31 |
2009-08-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity
|
PL2708558T3
(pl)
|
2008-04-11 |
2018-09-28 |
Chugai Seiyaku Kabushiki Kaisha |
Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
|
AU2009267294B2
(en)
|
2008-06-30 |
2014-06-26 |
Kyowa Kirin Co., Ltd. |
Anti-CD27 antibody
|
CN103145835B
(zh)
|
2008-07-17 |
2014-10-29 |
协和发酵麒麟株式会社 |
抗-系统asc氨基酸转运蛋白2 (asct2)抗体
|
WO2010018847A1
(ja)
|
2008-08-13 |
2010-02-18 |
協和発酵キリン株式会社 |
遺伝子組換えプロテインs組成物
|
US8481033B2
(en)
|
2008-10-07 |
2013-07-09 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)
|
KR20160062207A
(ko)
*
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항nr10 항체 및 그의 이용
|
JP5139517B2
(ja)
*
|
2008-12-05 |
2013-02-06 |
中外製薬株式会社 |
抗nr10抗体、およびその利用
|
PL2374883T3
(pl)
|
2008-12-26 |
2017-05-31 |
Kyowa Hakko Kirin Co., Ltd. |
Przeciwciało anty-CD4
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
EP2408818A1
(de)
|
2009-03-17 |
2012-01-25 |
Université de la Méditerranée |
Btla-antikörper und anwendungen davon
|
WO2010107110A1
(ja)
|
2009-03-19 |
2010-09-23 |
中外製薬株式会社 |
抗体定常領域改変体
|
TWI646193B
(zh)
|
2009-03-19 |
2019-01-01 |
中外製藥股份有限公司 |
抗體恆定區域改變體
|
PT2423228E
(pt)
|
2009-04-20 |
2016-02-26 |
Kyowa Hakko Kirin Co Ltd |
Anticorpo contendo igg2 em que foram introduzidas mutações de aminoácidos
|
MX2012001708A
(es)
|
2009-08-07 |
2012-05-22 |
Kyowa Hakko Kirin Co Ltd |
Anticuerpo humanizado anti-oligomero de amiloide b.
|
JP5692073B2
(ja)
|
2009-08-07 |
2015-04-01 |
協和発酵キリン株式会社 |
抗アミロイドβオリゴマーヒト化抗体
|
AU2010293383B2
(en)
|
2009-09-10 |
2014-12-18 |
Kyowa Kirin Co., Ltd. |
Medicament including antibody composition specifically bound to human CC chemokine receptor 4 (CCR4)
|
US10150808B2
(en)
|
2009-09-24 |
2018-12-11 |
Chugai Seiyaku Kabushiki Kaisha |
Modified antibody constant regions
|
JP5820800B2
(ja)
|
2010-03-02 |
2015-11-24 |
協和発酵キリン株式会社 |
改変抗体組成物
|
JP5889181B2
(ja)
|
2010-03-04 |
2016-03-22 |
中外製薬株式会社 |
抗体定常領域改変体
|
JP5767207B2
(ja)
|
2010-03-26 |
2015-08-19 |
協和発酵キリン株式会社 |
新規修飾部位導入抗体および抗体フラグメント
|
KR101846590B1
(ko)
|
2010-06-11 |
2018-04-09 |
교와 핫꼬 기린 가부시키가이샤 |
항 tim-3 항체
|
US9040671B2
(en)
|
2010-07-23 |
2015-05-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods for cancer management targeting Co-029
|
DK2644698T3
(en)
|
2010-11-17 |
2018-01-22 |
Chugai Pharmaceutical Co Ltd |
MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE WITH ALTERNATIVE FUNCTION TO BLOOD COAGULATION FACTOR FUNCTION VIII
|
EP2647706B1
(de)
|
2010-11-30 |
2023-05-17 |
Chugai Seiyaku Kabushiki Kaisha |
Antigenbindende moleküle zur wiederholten bindung an mehrere antigenmoleküle
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
US20130273062A1
(en)
|
2010-12-22 |
2013-10-17 |
Orega Biotech |
Antibodies against human cd39 and use thereof
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
CN103517918A
(zh)
|
2011-03-01 |
2014-01-15 |
诺沃—诺迪斯克有限公司 |
拮抗性dr3配体
|
DK2691417T3
(en)
|
2011-03-29 |
2018-11-19 |
Roche Glycart Ag |
ANTIBODY FC VARIANTS
|
SG10201602322TA
(en)
|
2011-03-31 |
2016-05-30 |
Inserm Inst Nat De La Santé Et De La Rech Médicale |
Antibodies directed against icos and uses thereof
|
JP5980202B2
(ja)
|
2011-05-09 |
2016-08-31 |
株式会社ペルセウスプロテオミクス |
トランスフェリン受容体を特異的に認識できる抗体
|
EP2710040B1
(de)
|
2011-05-19 |
2017-07-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-human-her3-antikörper und deren verwendungen
|
WO2012176779A1
(ja)
|
2011-06-20 |
2012-12-27 |
協和発酵キリン株式会社 |
抗erbB3抗体
|
US9249228B2
(en)
|
2011-06-22 |
2016-02-02 |
Oribase Pharma |
Anti-Axl antibodies and uses thereof
|
US9409988B2
(en)
|
2011-06-22 |
2016-08-09 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-Axl antibodies and uses thereof
|
EP2543677A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
EP2543679A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
EP2543678A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
CA2853230C
(en)
|
2011-10-31 |
2021-11-23 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
|
JP2014533246A
(ja)
*
|
2011-11-01 |
2014-12-11 |
メディミューン,エルエルシー |
喘息の急性増悪の頻度および重症度を低下させる方法
|
WO2014001368A1
(en)
|
2012-06-25 |
2014-01-03 |
Orega Biotech |
Il-17 antagonist antibodies
|
KR102143476B1
(ko)
|
2012-07-02 |
2020-08-12 |
쿄와 기린 가부시키가이샤 |
항bmp9 항체를 유효 성분으로 하는, 신장성 빈혈, 암성 빈혈 등의 빈혈에 대한 치료제
|
PL3495387T3
(pl)
|
2012-07-13 |
2022-01-10 |
Roche Glycart Ag |
Dwuswoiste przeciwciała anty-VEGF/anty-ANG-2 i ich zastosowanie w leczeniu chorób naczyniowych oka
|
EP2892928B1
(de)
|
2012-09-03 |
2018-05-30 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Gegen icos gerichtete antikörper zur behandlung der graft-versus-host-erkrankung
|
ES2773107T3
(es)
|
2012-10-05 |
2020-07-09 |
Kyowa Kirin Co Ltd |
Composición de proteína heterodimérica
|
CN104797600A
(zh)
|
2012-11-08 |
2015-07-22 |
国立大学法人宫崎大学 |
能够特异性识别转铁蛋白受体的抗体
|
EP2733153A1
(de)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Herstellung von Immunkonjugaten und Verwendungen davon
|
RS60043B1
(sr)
|
2012-11-20 |
2020-04-30 |
Sanofi Sa |
Anti-ceacam5 antitela i njihova primena
|
EP2930240B1
(de)
|
2012-12-07 |
2018-08-01 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-folr1-antikörper
|
EP3400961B1
(de)
|
2012-12-27 |
2021-02-24 |
Sanofi |
Anti-lamp1 antikörper und antikörper-konjugate und deren verwendung
|
US10005839B2
(en)
|
2013-05-17 |
2018-06-26 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antagonist of the BTLA/HVEM interaction for use in therapy
|
RS58404B1
(sr)
|
2013-08-12 |
2019-04-30 |
Astrazeneca Ab |
Metode za smanjenje stopa pogoršavanja astme korišćenjem benralizumaba
|
BR112016002462A8
(pt)
|
2013-08-12 |
2018-06-12 |
Medimmune Llc |
Métodos para melhorar os sintomas da asma usando benralizumabe
|
ES2733602T3
(es)
|
2013-08-12 |
2019-12-02 |
Astrazeneca Ab |
Métodos para incrementar el volumen espiratorio forzado en pacientes asmáticos que usan benralizumab
|
JP6552412B2
(ja)
|
2013-09-05 |
2019-07-31 |
国立大学法人 宮崎大学 |
ヒトインテグリンa6b4と特異的に反応する抗体
|
EP3050896B1
(de)
|
2013-09-27 |
2021-07-07 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur herstellung eines polypeptid-heteromultimers
|
KR20160061352A
(ko)
*
|
2013-10-15 |
2016-05-31 |
메디뮨 엘엘씨 |
벤랄리주맙을 사용하여 만성 폐쇄성 폐 질환을 치료하는 방법
|
KR102109053B1
(ko)
*
|
2013-10-24 |
2020-05-13 |
아스트라제네카 아베 |
안정한 수성 항체 제제
|
ES2865196T3
(es)
|
2013-11-07 |
2021-10-15 |
Inst Nat Sante Rech Med |
Anticuerpos anti-HER3 humana alostéricos de neuregulina
|
WO2015158851A1
(en)
|
2014-04-16 |
2015-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
ES2726645T3
(es)
|
2014-08-01 |
2019-10-08 |
Inst Nat Sante Rech Med |
Un anticuerpo anti-CD45RC para usar como medicamento
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
WO2016059220A1
(en)
|
2014-10-16 |
2016-04-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tcr-activating agents for use in the treatment of t-all
|
TN2017000275A1
(en)
|
2015-01-23 |
2018-10-19 |
Sanofi Sa |
Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
|
MA41414A
(fr)
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
ES2836432T3
(es)
|
2015-03-18 |
2021-06-25 |
Janssen Vaccines & Prevention Bv |
Ensayos para sistemas de expresión recombinante
|
US11142587B2
(en)
|
2015-04-01 |
2021-10-12 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing polypeptide hetero-oligomer
|
US20180071413A1
(en)
|
2015-04-07 |
2018-03-15 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Non-invasive imaging of tumor pd-l1 expression
|
CN107614016B
(zh)
|
2015-04-14 |
2022-06-17 |
中外制药株式会社 |
包含il-31拮抗剂作为活性成分的用于预防和/或治疗特应性皮炎的药物组合物
|
CA2988085A1
(en)
|
2015-06-01 |
2016-12-08 |
University Of Toyama |
Interleukin-5 receptor antibodies for the treatment of pulmonary hypertension
|
US20180201687A1
(en)
|
2015-07-07 |
2018-07-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to myosin 18a and uses thereof
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
EP3370768B9
(de)
*
|
2015-11-03 |
2022-03-16 |
Janssen Biotech, Inc. |
Spezifisch an pd-1 bindende antikörper und deren verwendung
|
JP2018538249A
(ja)
|
2015-11-04 |
2018-12-27 |
アストラゼネカ アクチボラグ |
好酸球性疾患における好酸球標的化治療薬に対する臨床応答の予測変数としてのジペプチジルペプチダーゼ−4およびペリオスチン
|
EP3398965A4
(de)
|
2015-12-28 |
2019-09-18 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur förderung der effizienz der reinigung von polypeptid mit fc-region
|
CA3013333A1
(en)
|
2016-02-26 |
2017-08-31 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antibodies having specificity for btla and uses thereof
|
EP3431102A4
(de)
|
2016-03-14 |
2019-09-25 |
Chugai Seiyaku Kabushiki Kaisha |
Zellschadeninduzierendes therapeutisches arzneimittel zur verwendung in der krebstherapie
|
CN109313201B
(zh)
*
|
2016-06-14 |
2022-04-01 |
高级生物设计公司 |
用于监测细胞凋亡的特异于γ-谷氨酰基-L-ε-赖氨酸(GGEL)的单克隆抗体
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
WO2018020000A1
(en)
|
2016-07-29 |
2018-02-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies targeting tumor associated macrophages and uses thereof
|
US11286295B2
(en)
|
2016-10-20 |
2022-03-29 |
Sanofi |
Anti-CHIKV monoclonal antibodies directed against the E2 structural protein
|
WO2018091720A1
(en)
|
2016-11-21 |
2018-05-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the prophylactic treatment of metastases
|
JPWO2018139404A1
(ja)
*
|
2017-01-24 |
2019-11-14 |
協和キリン株式会社 |
放射線障害の治療又は予防剤並びに治療又は予防方法
|
JP2020510432A
(ja)
|
2017-03-02 |
2020-04-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Nectin−4への特異性を有する抗体及びその使用
|
EP3596124A1
(de)
|
2017-03-16 |
2020-01-22 |
Innate Pharma |
Zusammensetzungen und verfahren zur behandlung von krebs
|
CN110914430B
(zh)
|
2017-07-13 |
2023-11-21 |
协和麒麟株式会社 |
抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法
|
JP7197865B2
(ja)
|
2017-07-18 |
2022-12-28 |
協和キリン株式会社 |
抗ヒトccr1モノクローナル抗体
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
EP3684795A1
(de)
|
2017-09-21 |
2020-07-29 |
Imcheck Therapeutics SAS |
Antikörper mit spezifizität für btn2 und verwendungen davon
|
RU2698048C2
(ru)
*
|
2017-10-03 |
2019-08-21 |
Закрытое Акционерное Общество "Биокад" |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
|
US11773180B2
(en)
|
2017-11-08 |
2023-10-03 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody which binds to CD40 and EpCAM
|
AU2018384239A1
(en)
|
2017-12-12 |
2020-07-02 |
Kyowa Kirin Co., Ltd. |
Anti-BMP10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising said antibody as active ingredient
|
CN109942706A
(zh)
|
2017-12-21 |
2019-06-28 |
三生国健药业(上海)股份有限公司 |
结合人il-5的单克隆抗体、其制备方法和用途
|
CA3099893A1
(en)
|
2018-06-18 |
2019-12-26 |
Innate Pharma |
Compositions and methods for treating cancer
|
WO2020004490A1
(ja)
|
2018-06-26 |
2020-01-02 |
協和キリン株式会社 |
コンドロイチン硫酸プロテオグリカン-5に結合する抗体
|
JP7397445B2
(ja)
|
2018-06-26 |
2023-12-13 |
協和キリン株式会社 |
Cell Adhesion Molecule3に結合する抗体
|
WO2020067541A1
(ja)
|
2018-09-28 |
2020-04-02 |
協和キリン株式会社 |
抗体組成物
|
EP3877413A1
(de)
|
2018-11-06 |
2021-09-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und pharmazeutische zusammensetzungen zur behandlung von akuter myeloischer leukämie durch vernichtung von leukämischen stammzellen
|
US20220332838A1
(en)
|
2018-11-20 |
2022-10-20 |
Perseus Proteomics Inc. |
Agent for inhibiting iron uptake into cells
|
WO2020120786A1
(en)
|
2018-12-14 |
2020-06-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs
|
BR112021012569A2
(pt)
|
2018-12-28 |
2021-09-14 |
Kyowa Kirin Co., Ltd. |
Anticorpo biespecífico de ligação ao tfr
|
CN111100210B
(zh)
*
|
2019-01-30 |
2022-04-19 |
武汉九州钰民医药科技有限公司 |
一种Fc融合蛋白及其应用
|
WO2020169472A2
(en)
|
2019-02-18 |
2020-08-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of inducing phenotypic changes in macrophages
|
EP3941940A1
(de)
|
2019-03-20 |
2022-01-26 |
Imcheck Therapeutics SAS |
Antikörper mit spezifizität für btn2 und verwendungen davon
|
JP2022526334A
(ja)
|
2019-03-25 |
2022-05-24 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
新たなタウ種を標的化することによるタウオパチー障害の処置の方法
|
US20220259328A1
(en)
|
2019-05-15 |
2022-08-18 |
Kyowa Kirin Co., Ltd. |
Bispecific antibody binding to cd40 and fap
|
TW202108625A
(zh)
|
2019-05-15 |
2021-03-01 |
日商協和麒麟股份有限公司 |
與cd40及gpc3結合之雙專一性抗體
|
TW202110479A
(zh)
|
2019-05-16 |
2021-03-16 |
瑞典商阿斯特捷利康公司 |
使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法
|
SG11202112561UA
(en)
|
2019-06-06 |
2021-12-30 |
Immatics Biotechnologies Gmbh |
Sorting with counter selection using sequence similar peptides
|
WO2021023624A1
(en)
|
2019-08-02 |
2021-02-11 |
Orega Biotech |
Novel il-17b antibodies
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
WO2021045184A1
(ja)
|
2019-09-04 |
2021-03-11 |
株式会社ペルセウスプロテオミクス |
多血症治療薬
|
TW202124425A
(zh)
|
2019-09-13 |
2021-07-01 |
日商協和麒麟股份有限公司 |
DcR3改型體
|
US20220324962A1
(en)
|
2019-09-27 |
2022-10-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance antibodies and uses thereof
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
TW202126688A
(zh)
|
2019-09-27 |
2021-07-16 |
瑞典商阿斯特捷利康公司 |
使用貝那利珠單抗治療遲發性氣喘之方法
|
US20220380489A1
(en)
|
2019-10-02 |
2022-12-01 |
Kyushu University, National University Corporation |
Method for producing heparin-like substance, recombinant cell, and method for producing the same
|
JP6845973B1
(ja)
|
2019-11-20 |
2021-03-24 |
中外製薬株式会社 |
抗体含有製剤
|
US20230037414A1
(en)
|
2019-11-22 |
2023-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Inhibitors of adrenomedullin for the treatment of acute myeloid leukemia by eradicating leukemic stem cells
|
EP4066858A4
(de)
|
2019-11-27 |
2023-12-27 |
Perseus Proteomics Inc. |
Therapeutisches mittel für karzinomatöse peritonitis
|
US20230040928A1
(en)
|
2019-12-09 |
2023-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
JP2023525423A
(ja)
|
2020-01-15 |
2023-06-16 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Prameに特異的に結合する抗原結合タンパク質
|
TW202140561A
(zh)
|
2020-02-14 |
2021-11-01 |
日商協和麒麟股份有限公司 |
與cd3結合之雙特異性抗體
|
AU2021249888A1
(en)
|
2020-04-01 |
2022-10-27 |
Kyowa Kirin Co., Ltd. |
Antibody composition
|
US20230181753A1
(en)
|
2020-05-12 |
2023-06-15 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas
|
TW202214692A
(zh)
|
2020-06-05 |
2022-04-16 |
瑞典商阿斯特捷利康公司 |
治療患有鼻瘜肉的患者的重度氣喘之方法
|
CN111825763B
(zh)
*
|
2020-07-15 |
2022-04-19 |
扬州大学 |
流感病毒ha蛋白茎部特异性单克隆抗体及其制备方法和应用
|
CN114075282B
(zh)
*
|
2020-08-20 |
2024-01-02 |
南京融捷康生物科技有限公司 |
Il-5的结合分子及其制备方法和应用
|
AU2021335257A1
(en)
|
2020-09-04 |
2023-03-09 |
Merck Patent Gmbh |
Anti-CEACAM5 antibodies and conjugates and uses thereof
|
KR20220035655A
(ko)
|
2020-09-14 |
2022-03-22 |
아주대학교산학협력단 |
인터루킨-4 수용체 알파 서브유닛과 인터루킨-5 수용체 알파 서브유닛에 동시에 결합하는 이중특이항체 및 이의 용도
|
KR20220035656A
(ko)
*
|
2020-09-14 |
2022-03-22 |
아주대학교산학협력단 |
인간 IL-5Rα에 결합하는 항체 및 이의 용도
|
JPWO2022075439A1
(de)
|
2020-10-08 |
2022-04-14 |
|
|
JP2023553641A
(ja)
|
2020-12-17 |
2023-12-25 |
アストラゼネカ アクチボラグ |
抗il5r抗体製剤
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
IL308257A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins that uniquely bind PRAME
|
KR20240038028A
(ko)
|
2021-07-27 |
2024-03-22 |
이매틱스 바이오테크놀로지스 게엠베하 |
Ct45에 특이적으로 결합하는 항원 결합 단백질
|
IL310437A
(en)
|
2021-07-29 |
2024-03-01 |
Inst Nat Sante Rech Med |
Humanized anti-human βig-h3 protein and uses thereof
|
CN117836326A
(zh)
|
2021-08-26 |
2024-04-05 |
协和麒麟株式会社 |
与cd116和cd131结合的双特异性抗体
|
WO2023027164A1
(ja)
|
2021-08-26 |
2023-03-02 |
株式会社ペルセウスプロテオミクス |
Ros(活性酸素種)産生増強剤
|
WO2023170240A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
CN115043934B
(zh)
*
|
2022-03-31 |
2023-06-27 |
深圳市人民医院 |
靶向新冠病毒的纳米抗体及其制备方法和应用
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|